Stockreport

Should New HEPZATO Subgroup Data and Delcath's Targeted Strategy Require Action From DCTH Investors? [Yahoo! Finance]

Delcath Systems, Inc.  (DCTH) 
US:NASDAQ Investor Relations: delcath.com/investors
PDF melanoma were published in the Journal of Cancer Research and Clinical Oncology, detailing efficacy and safety outcomes across different patient characteristics. The p [Read more]